Biophytis S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALBPS.PA research report →
About the company
Biophytis S. A. is a clinical-stage biotechnology company dedicated to creating therapies designed to mitigate age-related degenerative processes and enhance functional well-being for patients.
- CEO
- Stanislas Veillet
- IPO
- 2015
- Employees
- 22
- HQ
- Paris, FR
Price Chart
- Market Cap
- $355.43K
- P/E
- -0.02
- P/S
- 0.00
- P/B
- -0.04
- EV/EBITDA
- -1.02
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 92.02%
- ROIC
- -3022.97%
- Revenue
- $0 · 0.00%
- Net Income
- $-10,379,000 · 39.04%
- EPS
- $-2.00 · 84.06%
- Op Income
- $-8,500,000
- FCF YoY
- 33.99%
- 52W High
- $0.22
- 52W Low
- $0.02
- 50D MA
- $0.02
- 200D MA
- $0.06
- Beta
- 0.89
- Avg Volume
- 4.32M
Get TickerSpark's AI analysis on ALBPS.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALBPS.PA coverage
Recent articles, reports, and earnings notes.
No research on ALBPS.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALBPS.PA report →Similar companies
Peers in the same neighborhood.